Study Title
Study Details
The objective of the study is to evaluate the sensibility of the probe Forimtech to detect β+ emission in vivo in humans and its usefulness during elective surgical procedure Hypothesis:The probe Forimtech is able to allow per-surgery detection of tumoral lesions sensible to 18F-FDG and to help in the realization of guided biopsies, minimally invasive surgery or complement of resection of tumors. The β+ emission detected by the probe Forimtech is correlated to the emission γ detected by the 18F-FDG.PET/CT
University of Lausanne Hospitals
John O Prior, PhD MD (Principal Investigator)
john.prior@chuv.ch +41 21 314 43 48Christine Geldhof
christine.geldhof@chuv.ch +41 21 314 43 46NCT02666599 - Click to see study on ClinicalTrials.gov
Inclusion
Inclusion Criteria Not Yet Provided
Exclusion
Exclusion Criteria Not Yet Provided